Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
US Market

Aerovate Therapeutics (AVTE) Financial Statements

Compare
125 Followers

Aerovate Therapeutics Financial Overview

Aerovate Therapeutics's market cap is currently $72.75M. The company's EPS TTM is $-2.445; its P/E ratio is ―; Aerovate Therapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -96.00K$ -68.00K$ -15.00K$ -1.00K
Operating Income$ -74.60M$ -81.41M$ -53.24M$ -23.02M$ -8.89M
EBITDA$ -74.31M$ -81.31M$ -53.17M$ -23.01M$ -8.89M
Net Income$ -69.63M$ -75.52M$ -51.51M$ -22.96M$ -9.04M
Balance Sheet
Cash & Short-Term Investments$ 78.62M$ 122.44M$ 129.22M$ 167.38M$ 4.57M
Total Assets$ 80.33M$ 127.42M$ 135.30M$ 175.36M$ 4.71M
Total Debt$ 417.00K$ 675.00K$ 1.09M$ 574.00K$ 0.00
Net Debt$ -33.33M$ -22.82M$ -21.31M$ -53.62M$ -4.57M
Total Liabilities$ 3.90M$ 17.96M$ 8.56M$ 2.94M$ 18.06M
Stockholders' Equity$ 76.43M$ 109.46M$ 126.74M$ 172.42M$ -13.34M
Cash Flow
Free Cash Flow$ -71.20M$ -56.92M$ -39.32M$ -27.58M$ -7.86M
Operating Cash Flow$ -71.20M$ -56.78M$ -39.12M$ -27.40M$ -7.86M
Investing Cash Flow$ 56.03M$ 11.88M$ 6.93M$ -113.43M$ 0.00
Financing Cash Flow$ 25.43M$ 46.00M$ 396.00K$ 190.46M$ 8.92M
Currency in USD

Aerovate Therapeutics Earnings and Revenue History

Aerovate Therapeutics Debt to Assets

Aerovate Therapeutics Cash Flow

Aerovate Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis